Compare OLMA & BFST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OLMA | BFST |
|---|---|---|
| Founded | 2006 | 2006 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 994.9M | 944.4M |
| IPO Year | 2020 | 2014 |
| Metric | OLMA | BFST |
|---|---|---|
| Price | $11.49 | $30.49 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 10 | 4 |
| Target Price | ★ $44.89 | $32.75 |
| AVG Volume (30 Days) | ★ 1.9M | 290.1K |
| Earning Date | 05-08-2026 | 04-27-2026 |
| Dividend Yield | N/A | ★ 2.23% |
| EPS Growth | 15.00 | ★ 23.45 |
| EPS | N/A | ★ 0.68 |
| Revenue | N/A | ★ $10,704,000.00 |
| Revenue This Year | N/A | $22.71 |
| Revenue Next Year | N/A | $5.02 |
| P/E Ratio | ★ N/A | $45.37 |
| Revenue Growth | N/A | ★ 1.20 |
| 52 Week Low | $4.47 | $22.56 |
| 52 Week High | $36.26 | $31.57 |
| Indicator | OLMA | BFST |
|---|---|---|
| Relative Strength Index (RSI) | 47.01 | 53.31 |
| Support Level | $7.79 | $29.50 |
| Resistance Level | $13.09 | $31.57 |
| Average True Range (ATR) | 0.65 | 0.73 |
| MACD | -0.03 | -0.06 |
| Stochastic Oscillator | 31.20 | 43.34 |
Olema Pharmaceuticals inc is a clinical-stage biopharmaceutical company. It is focused on the discovery, development, and commercialization of next generation targeted therapies for women's cancers. Its therapies offer the potential to improve outcomes for women living with cancer. The company has completed discovery and preclinical studies of OP-1250. OP-3136 is another drug candidate in the company's product pipeline.
Business First Bancshares Inc is a bank holding company. The company's services include personal and commercial banking, treasury management, and wealth solutions. It provides a range of financial services to small-to-midsized businesses and professionals. The company generates the majority of its revenues from interest income on loans, customer service and loan fees, and interest income from securities.